Literature DB >> 7948014

Evaluation in vivo of the differential uptake and processing of high-density lipoprotein unesterified cholesterol and cholesteryl ester in the rat.

E Bravo1, K M Botham, M A Mindham, P A Mayes, T Marinelli, A Cantafora.   

Abstract

The uptake and processing of high-density lipoprotein (HDL) unesterified and esterified cholesterol were compared in vivo in the rat. HDL labelled with 3H in either unesterified cholesterol or cholesteryl ester was administered intravenously, and the clearance of radioactivity from the blood, its distribution in plasma lipoprotein density fractions, uptake by tissues, and appearance in bile were studied at intervals up to 180 min. 3H in HDL unesterified cholesterol was cleared more rapidly from the blood than that in HDL cholesteryl ester, and this difference was mainly due to rapid sequestration of [3H]unesterified cholesterol by the liver, with 58.2% of the administered dose found in this tissue after 10 min, compared to 6.8% of the [3H]cholesteryl ester dose. Non-hepatic tissues took up only a small proportion of the administered label from both HDL unesterified and esterified cholesterol, but on a per gram wet weight basis, the specific uptake of HDL cholesteryl ester in the adrenal glands and the spleen was higher than in the liver, particularly in the first 60 min. The distribution of radioactivity in the plasma lipoprotein density fractions remained constant between 10 and 180 min when [3H]unesterified cholesterol was used, but the proportion of plasma radioactivity from HDL labelled in esterified cholesterol in the very-low-density lipoprotein (VLDL) fraction increased from 0% to 26%, while in HDL there was a shift in the distribution of radioactivity from the most (d 1.125-1.250 g/ml) to the least (d 1.050-1.085 g/ml) dense sub-fractions. A greater percentage of the administered label from HDL unesterified cholesterol (8.8%) than from HDL cholesteryl ester (3.3%) was secreted into bile during 180 min, but the proportions secreted in bile acids and unesterified cholesterol were similar with both labels. These findings indicate that there are significant differences in the uptake and processing of HDL unesterified as compared to esterified cholesterol in the rat in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948014     DOI: 10.1016/0005-2760(94)90096-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.

Authors:  Helen H Wang; Piero Portincasa; Ornella de Bari; Kristina J Liu; Gabriella Garruti; Brent A Neuschwander-Tetri; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-02-19       Impact factor: 4.686

2.  P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo.

Authors:  Marine Goffinet; Claudine Tardy; Nadia Boubekeur; Guy Cholez; Alice Bluteau; Daniela C Oniciu; Narendra D Lalwani; Jean-Louis H Dasseux; Ronald Barbaras; Rudi Baron
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

3.  High-density lipoprotein endocytosis in endothelial cells.

Authors:  Stefanie Fruhwürth; Margit Pavelka; Robert Bittman; Werner J Kovacs; Katharina M Walter; Clemens Röhrl; Herbert Stangl
Journal:  World J Biol Chem       Date:  2013-11-26

4.  HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation.

Authors:  Claudine Tardy; Marine Goffinet; Nadia Boubekeur; Guy Cholez; Rose Ackermann; Gavin Sy; Constance Keyserling; Narendra Lalwani; John F Paolini; Jean-Louis Dasseux; Ronald Barbaras; Rudi Baron
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

5.  Lipoprotein Particles Interact with Membranes and Transfer Their Cargo without Receptors.

Authors:  Birgit Plochberger; Taras Sych; Florian Weber; Jiri Novacek; Markus Axmann; Herbert Stangl; Erdinc Sezgin
Journal:  Biochemistry       Date:  2020-11-04       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.